Merck CEO Kenneth Frazier on Thursday said he’s encouraged by an initial meeting he and other pharmaceutical executives had Tuesday with Trump, who has said drugmakers have been The pharmaceutical industry has come under fire in recent months over soaring drug prices, which have been blasted by patients, doctors, politicians and others. Drug companies and investors have been alternatively worried that the Trump administration and Congress will move to reduce prices, and cheered by hopes that they will help them increase profits by reducing taxes and reducing regulations so they can bring new drugs to market faster.
Category: Lung Cancer
Cancer in women rising far faster than rates in men
Cancer in women is rising six times faster than cancer in men, with obesity partly to blame, new figures show. Data published by Cancer Research UK showed that unhealthy lifestyles are contributing to a rise in cancer cases among both sexes, but women are bearing the brunt of the increase.
Too Few Current, Former Smokers Screened for Lung Cancer
Most current and former smokers in the United States don’t get screened for lung cancer even though they’re at increased risk for the deadly disease, a new study reveals. The findings highlight the need to educate doctors and at-risk patients about lung cancer screening, according to the American Cancer Society researchers.
Too few current, former smokers screened for lung cancer
Most current and former smokers in the United States don’t get screened for lung cancer even though they’re at increased risk for the deadly disease, a new study reveals. The findings highlight the need to educate doctors and at-risk patients about lung cancer screening, according to the American Cancer Society researchers.
Merck 2017 forecast eases concerns over royalty payments, dollar
Merck & Co Inc reported better-than-expected U.S. quarterly sales for its key cancer drug, Keytruda, and forecast largely in-line 2017 results, which some analysts said allayed concerns over the impact of a strong dollar and royalty payments. The logo of Merck is pictured in this illustration photograph in Cardiff, California April 26, 2016.
Lower incidence of esophagitis in elderly NSCLC patients undergoing definitive radiation
Elderly non-small cell lung cancer patients undergoing definitive radiation have a lower incidence of esophagitis compared to younger patients and tolerate aggressive standard treatment regimens. Lung cancer is the leading cause of cancer deaths worldwide, causing more deaths than breast, colon, and prostate cancers combined.
The Battle For Bristol-Myers Begins
Bristol-Myers has activist investor Barry Rosenstein and his JANA Partners as a shareholder. JANA hasn’t announced any plans, or even considered the stake activist.
Futility
This past December was a hard month. Bigelow lab where I work, lost our director, Graham Shimmield to colon cancer, and we lost a trustee to cancer, I lost a cousin to ovarian cancer, and a colleague lost her mother, also to cancer.
YRMC debuts Lung Screening Program
Dr. Abhinav Chandra, medical director for Yuma Regional Medical Center Cancer Center is shown here next to a CT scanner. YRMC recently announced the launch of a community-wide Lung Screening Program.
This Promising Prostate Cancer Treatment Could Be a Game-Changer
Cancer is among the scariest diagnosis a person can receive. According to the American Cancer Society’s “Cancer Facts & Figures 2016” report, there were an estimated 1.69 million new cases of cancer diagnosed in 2016, along with a projected 595,690 cancer deaths.
Vancouver study examines impact of mental health upon lung cancer survival rates
When it comes to health, the mind-body link has long been discussed and it may seem obvious that mental health would have an impact upon physical conditions. While the relationship between emotional distress and lung cancer survival rates has been of scientific interest for decades, longterm research has been limited.
Murine Study Finds Potential Boost for Ovarian Cancer Drug Olaparib
Researchers from the Chinese Academy of Sciences have discovered that the metabolic enzyme phosphoglycerate mutase 1 helps cancer cells repair their DNA and found that inhibiting PGAM1 sensitizes tumors to the cancer drug Olaparib . Their findings in the study ” Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells ,” which has been published in The Journal of Cell Biology , suggest that this FDA-approved ovarian cancer medicine has the potential to treat a wider range of cancer types than currently indicated.
Study looks at link between cancer, anxiety
It appears lung cancer patients with anxiety and depression die sooner, according to a study by a team of researchers that included Dr. Rob Olson from the Northern Medical Program and the BC Cancer Agency of the North. The study, published in the Journal of Pain and Symptom Management, is one of the first to explore a possible link between mental health and the survival rates of lung cancer patients.
Leap Therapeutics and Macrocure Complete Merger Transaction
Leap Therapeutics, Inc. , a biotechnology company developing targeted and immuno-oncology therapeutics, today announced the completion of its merger with Macrocure Ltd , with Macrocure becoming a wholly-owned subsidiary of Leap. Leap will be listed on The Nasdaq Global Market under the symbol “LPTX” and expects to begin trading on Tuesday, January 24, 2017.
Many With Advanced Lung Cancer Don’t Get Treatments That Might Help
Many U.S. patients with late-stage lung cancer do not receive treatments that could prolong their lives, a new study finds. Researchers at the University of California, Davis Comprehensive Cancer Center analyzed 1998-2012 data from the U.S. National Cancer Database.
RAF hero Anna reveals 45k charity mission after being told her cancer is terminal
RAF hero Anna Irwin has launched a A 45,000 fund-raising crusade to help fellow cancer sufferers – after being told her illness is incurable. The determined former Blythe Bridge High School pupil – who was diagnosed with lung cancer last April – is refusing to give up despite being told conventional treatment is no longer working.
European shares ease ahead of Trump inauguration
MILAN, Jan 20 European shares fell, posting their biggest weekly loss since before Donald Trump won the U.S presidential election in November, as investors grew cautious before his inauguration. The STOXX 600 closed 0.1 percent lower, marking a five-day loss of almost 1 percent.
Why Bristol-Myers Squibb Co Stock Is Slipping Today
An announcement that it won’t seek accelerated approval for a combination lung cancer therapy comprised of two key drugs isn’t sitting well with the market in light of Merck & Co. ‘s Lung cancer might not be the most common malignancy, but it is the deadliest.
Bristol-Myers Squibb stock sinks 7.2% after it says it won’t pursue…
The company said the decision was made “based on a review of the data available at this time,” and said it would say no more “in order to protect the integrity of ongoing registrational studies.” Leerink analyst Seamus Fernandez said the development was a “clear setback for BMY,” especially given a fall approval by rival drugmaker Merck in first-line lung cancer.
Study provides scientific insight into metastatic patterns of EGFR mutated NSCLCs
The discovery of several different subtypes of Non Small Cell Lung Cancer , the most frequent form of lung cancer, has been a major breakthrough in the fight against the leading cause of cancer-related death worldwide. With each subtype displaying peculiar clinic-pathological characteristics, they can be associated with outstanding responses to specific targeted agents, such as anti-tumor drugs and immunotherapy.
Bristol-Myers Falls Further Behind Merck in Lung Cancer Race
Bristol-Myers Squibb Co. fell after the drugmaker said it wouldn’t seek accelerated approval for a combination of its drugs to treat first-line lung cancer.
A New Drug Offers Hope for People With Deadly Cancers
A new drug is being developed that targets some aggressive cancers that are notoriously hard to cure. If the clinical trials that are underway continue to show promise, the drug may change the way some cancers are treated.
Firefighter cancer presumption a hot issue for workers comp in 2017
… firefighters if they meet specific criteria, such as at least 10 years of service and undergoing a pre-employment health screening. Similar legislation has failed in Montana in the past. Meanwhile, on the same day, Florida state Rep. Heather …
Hutchison China MediTech (Chi-Med) Release: Fruquintinib Combination Study In 1st-Line NSCLC
London: Monday, January 16, 2017: Hutchison China MediTech Limited today announces that it has initiated a Phase II study of a combination therapy using fruquintinib and Iressa in the first-line setting for patients with advanced or metastatic non-small cell lung cancer in China. Fruquintinib is a highly selective and potent oral inhibitor of vascular endothelial growth factor receptors .
American Lung Association offers steps to fight radonJanuary has been …
… and the American Lung Association in Ohio encourages Ohio residents to take these simple steps to protect their health from this invisible threat. 1. Test homes for radon. Inexpensive radon testing kits can be found at many hardware stores or …
For Merck, Keytruda Is ‘Extraordinarily Positive’ : More Squawk From Jim Cramer
Merck’s lung cancer treatment will get a speedy review by the FDA, but it ‘knows better than to go out and give false hope,’ TheStreet’s Jim Cramer said. Shares of Merck were higher in late morning trading Wednesday, after the company announced the U.S. Food and Drug Administration would make a decision by May 10 on its lung cancer treatment that combines the immune system-boosting drug Keytruda with chemotherapy.
Calgarians pledge to support Syrian refugee family after 29-year-old dad loses cancer battle
After a six-year battle with cancer, a Syrian refugee living in Calgary has passed away, leaving behind his wife and two young children. Majd Tahhouf was granted permission to come Canada with his wife, four-year-old son and two-year-old daughter in March 2015.
TDEC Encourages Tennesseans to Test for Radon During Radon Action Month
… the state to offer educational outreach events for those who would like to learn more. January 13, 2017 Lentz Public Health Center 2500 Charlotte Ave., Nashville TN 37209 10 a.m.-2 p.m. CST January 31, 2017 Legislative Plaza 301 6th Ave. N., …
EPA encourages homeowners to test for cancer-causing radon
The odorless colorless radon gas is the nation’s second-leading cause of lung cancer, behind smoking, and is the most common cause in nonsmokers. Nebraska has the nation’s third-highest prevalence of radon, the cancer-causing gas that seeps into buildings from the surrounding soil.
5 Tough Questions for Bristol-Myers Squibb’s CEO
But he’s gotten used to answering tough questions. On Thursday morning, the big drugmaker’s CEO sat down for around 40 minutes responding to nonstop questions at the Goldman Sachs Healthcare CEOs Unscripted event.
Cheating Death Can Cost $200,000 as Cancer Tops Pharma Sales
… revenue will propel innovation, the costs are stoking patients’ distress and creating a rift between manufacturers, health authorities and payers in many markets. Take the new lung-cancer drugs from Merck & Co., Bristol-Myers Squibb Co. and Roche …
Radon
… for those who would like to learn more. Nearby, events will be Jan. 13 from 10 a.m. until 2 p.m. at the Lentz Public Health Center at 2500 Charlotte Ave. in Nashville and Jan. 31 from 8 a.m. until 2:30 p.m. at the Legislative Plaza at 301 Sixth Ave. …
Chicago, public housing agencies to implement federal smoking ban
… agencies $153 million every year in repairs and preventable fires, including $94 million in secondhand smoke-related health care, $43 million in renovation of smoking-permitted units and $16 million in smoking-related fire losses. “Every child …
Ono Pharma’s Wild 2016 Ride Cuts Stock Valuation by $16 Billion
… in the sector,” says Nomura’s Kohtani, who rates Ono shares neutral. The troubles were compounded by the Japan Health Ministry’s decision in November to lower Opdivo’s price by half, forcing Ono to lower its profit outlook for the current fiscal …
Immunotherapy offers hope to cancer patients
Three months before physicians at Medical University Hospital discharged Madelyn Graf to hospice – some of them convinced that her cancer was incurable and her death was imminent – she came home from the gym perfectly healthy except for a stomach ache. But the pain became progressively intense that afternoon, wrapping around her torso.
Critical Care Provides Comprehensive Pulmonary Services for Treating Lung Diseases
A leading pulmonologist in Denver, Critical Care, Pulmonary & Sleep Associates offers Pulmonary Services for treating patients with common or chronic breathing problems. Their team of lung doctors is board certified in Pulmonary Medicine and they provide pulmonary consultations for patients in outpatient clinics, as well as for those hospitalized in Denver metro hospitals.
See what happens to your body in the hours, days, weeks, months and years after you quit smoking
As many people quit smoking for their New Year’s resolution, here’s a breakdown of what happens to your body As 2017 gets under way, many smokers will have taken their last puff – and there’s no doubt that quitting smoking is the best thing they can do for their health. We know that we all die eventually, but smokers die on average 10 years earlier and tragically from much more painful and debilitating illnesses, such as lung cancer, heart attacks and strokes.
Watch: New breathalyser to diagnose diseases with just one puff
… others, each disease has a chemical signature that distinguishes it from other diseases and from a normal state of health. These odour signatures are what enables us to identify the diseases using the technology that we developed,” Haick said. With …
William Christopher, M*A*S*H actor, the last celebrity death of 2016
Everyone thought Ronda Rousey’s career was the last celebrity death of 2016, but then William Christopher, the famed M*A*S*H actor, passed away at 84 from lung cancer. It’s been a long year full of meltdowns and celebrity takeaways, but let’s be thankful that he reached 84 and send him off with well wishes.
Keeping your eyes healthy in 2017
It’s that time of year again and New Year resolutions are coming at you from every health corner. Here in RNIB Cymru we support people with sight loss, but our work also includes campaigns to help with preventing sight loss.